Other studies indicate that HMGB1 may be an important marker for assessing tumour staging and predicting prognosis in hepatocellular carcinoma, as HMGB1 levels in hepatocellular carcinoma were significantly higher than in chronic hepatitis, cirrhosis and healthy controls. Here, HMGB1 is linked to Cirrhosis.